Skip to content
ppharmaranks
Menu
Class IIOngoing

Prasugrel Tablets recall

FDA recall D-0280-2025 · initiated Feb 25, 2025

By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Mar 26, 2025How we research

MYLAN PHARMACEUTICALS INC recalled Prasugrel Tablets in Feb 2025 — an FDA Class II recall (D-0280-2025) because Failed Dissolution Specifications - low dissolution results.

May cause temporary or medically reversible harm; low probability of serious harm.

Why it was recalled

Failed Dissolution Specifications - low dissolution results

Wrong strength, or it did not keep

The product did not contain what the label promised, or stopped meeting specification before its expiry date. Under-strength medicine can mean an untreated condition.

This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.

Is your product affected? Check the lot number

A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.

Lot # 3211073, 3211074, 3211075, Exp 4/30/2026

Quantity recalled: N/A

Details

Product
Prasugrel Tablets, USP, 5 mg, 30-count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A., NDC 0378-5185-93
Recalling company
Mylan Gmbh
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
US Nationwide.
Initiated
Feb 25, 2025
FDA report date
Mar 26, 2025
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.

Frequently asked

Was Prasugrel Tablets recalled?
MYLAN PHARMACEUTICALS INC recalled Prasugrel Tablets in Feb 2025 — an FDA Class II recall (D-0280-2025) because Failed Dissolution Specifications - low dissolution results. May cause temporary or medically reversible harm; low probability of serious harm.
Why was Prasugrel Tablets recalled?
Per the FDA enforcement record, the reason for recall D-0280-2025 was: Failed Dissolution Specifications - low dissolution results
Is a recalled Prasugrel Tablets dangerous to take?
An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
Which lots of Prasugrel Tablets are affected?
Distributed: US Nationwide.. The recall covers these lots — Lot # 3211073, 3211074, 3211075, Exp 4/30/2026. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0280-2025.

Source: openFDA Drug Enforcement record D-0280-2025

← All drug recalls